Company of the year award

Frost & Sullivan is pleased to present the 2009 Company of the Year Award in the drug discovery technologies market to Life Technologies. According to Frost & Sullivan, the company's size, product portfolio breadth, market segment leadership and strong future potential set it apart from any competitor in the life science research tools industry. Additionally the company - which was formed in 2008 by a merger of Applied Biosystems and Invitrogen - was praised for showing great commitment to providing innovative and enabling tools across the life science research continuum.

"Prior to the 2008 merger, Applied Biosystems held the largest percentage of market share in the microRNA, PCR reagents, capillary electrophoresis sequencing, qRT-PCR and life sciences mass spectrometry markets, while Invitrogen held the largest percentage of market share in the cell culture and protein expression and purification markets," explains Jonathan Witonsky, industry manager, drug discovery and clinical diagnostics, Frost & Sullivan.

"By merging, the new company, Life Technologies, holds a significant market share in nine additional market segments, including the nucleic acid purification and isolation market, the laboratory information management systems market, the cell-based assays market, the research ELISA market, the high content screening market, the liquid chromatography market, the protein electrophoresis market, the RNAi market and the proteomics array market."

Each year, Frost & Sullivan presents this award to a company that has demonstrated excellence in terms of business development, competitive strategy, customer satisfaction and leadership within a particular Frost & Sullivan Industry Research Group.

For more information about Life Technologies visit www.lifetechnologies.com